Across TCGA pan-cancer cohorts, GATA4 mass-spec protein differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of GATA4’s most consistent transcriptional readouts.
The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where GATA4 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types GATA4 is over-expressed in tumor, although a few such as PDAC show the opposite, repressed pattern.
PDAC are the cancer types where GATA4 tumor–normal differential expression is most reproducible.